However, for the subgroup that included HD patients and others, no significant association was found between each 1 pmol/L increase in the circulating OPG level and all-cause mortality (adjusted HR, 1.04; 95% CI, 1.00-1.08). This evidence concerns the gene TNFRSF11B and Huntington disease.